中肽生化目录肽版块全新呈现，致力于打造全球最全面的多肽供应平台！我们专业的学术团队将时刻追踪最新最热的研究动向，帮助您发现实际需求，并以最高质量标准提供您所需要的产品。我们将我们将不定期更新产品列表，为您最大限度地节约科研时间，敬请广大客户朋友关注！
LHRH-015B
Buserelin(NHNH2)
Pyr-His-Trp-Ser-Tyr-D-Ser(tBu)-Leu-Arg-Pro-NHNH2 Trifluoroacetate salt
Pyr-His-Trp-Ser-Tyr-D-Ser(tBu)-Leu-Arg-Pro-NHNH2 Trifluoroacetate salt
Size：25mg
P1(RMB)：1350
MW：1239.44
One letter sequence：Pyr-HWSYs(tBu)-LRP-NHNH2
Molecular Formula：C58H83N17O13
Description：Buserelin is a longer acting synthetic peptide analog of the naturally occurring gonadotropin-releasing hormone (GnRH/LHRH). Substitution of glycine in position 6 by D-serine and that of glycinamide in position 10 by ethylamide, leads to a nonapeptide with a significantly enhanced LHRH effect. The effects of buserelin on follicle-stimulating hormone (FSH) and luteinizing hormone (LH) release are approximately 20 to 170 times higher than those of natural LHRH.
Literature Reference：F.Roila, Biomed. Pharmacother., 43, 279 (1989) R.N.Brogden et al., Drugs, 39, 399 (1990) A.Imai et al., Am. J. Obstet. Gynecol., 182, 1142 (2000) Y.Wang et al., Eur. J. Endocrinol., 146, 447 (2002) A.Imai et al., Int. J. Oncol., 20, 987 (2002) J.Franklin et al., J. Endocrinol., 176, 275 (2003) Merck Index, 14th ed., No. 1503, (2006)
Cas：57982-77-1
P1(RMB)：1350
MW：1239.44
One letter sequence：Pyr-HWSYs(tBu)-LRP-NHNH2
Molecular Formula：C58H83N17O13
Description：Buserelin is a longer acting synthetic peptide analog of the naturally occurring gonadotropin-releasing hormone (GnRH/LHRH). Substitution of glycine in position 6 by D-serine and that of glycinamide in position 10 by ethylamide, leads to a nonapeptide with a significantly enhanced LHRH effect. The effects of buserelin on follicle-stimulating hormone (FSH) and luteinizing hormone (LH) release are approximately 20 to 170 times higher than those of natural LHRH.
Literature Reference：F.Roila, Biomed. Pharmacother., 43, 279 (1989) R.N.Brogden et al., Drugs, 39, 399 (1990) A.Imai et al., Am. J. Obstet. Gynecol., 182, 1142 (2000) Y.Wang et al., Eur. J. Endocrinol., 146, 447 (2002) A.Imai et al., Int. J. Oncol., 20, 987 (2002) J.Franklin et al., J. Endocrinol., 176, 275 (2003) Merck Index, 14th ed., No. 1503, (2006)
Cas：57982-77-1
